Wensheng Xie

Dr. Wensheng Xie


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
ZGZhenhu Guo
Zhenhu Guo
WXWensheng Xie
Wensheng Xie
JLJingsong Lu
Jingsong Lu
XGXiaoxiao Guo
Xiaoxiao Guo
JXJianzhong Xu
Jianzhong Xu
Lingyun ZhaoLingyun Zhao
Lingyun Zhao
Strategic design for the fabrication of tannic acid-based metal phenolic networks. Various applications of tannic acid-based metal phenolic networks in biomedical fields.

16 July 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
ZGZhenhu Guo
Zhenhu Guo
WXWensheng Xie
Wensheng Xie
JLJingsong Lu
Jingsong Lu
XGXiaoxiao Guo
Xiaoxiao Guo
YCYongjie Chi
Yongjie Chi
LZLingyun Zhao
Lingyun Zhao
Fe-Doped Mg–Al layer double hydroxide NPs were endowed with enhanced photo-induced ability and T 2 -weighted MR effect for cancer theranostic application.

26 September 2019 in Rare Metals
Verified
Journal Article
Closed access
PDF file
AYAli Yazdan
Ali Yazdan
JWJi‐Zhe Wang
Ji‐Zhe Wang
BHBing‐Kun Hu
Bing‐Kun Hu
WXWensheng Xie
Wensheng Xie
Lingyun ZhaoLingyun Zhao
Lingyun Zhao
LLLiang‐Liang Li
Liang‐Liang Li

Verified
Journal Article
Open access
PDF file
ZZZiyao Zhang
Ziyao Zhang
FZFangming Zhang
Fangming Zhang
WXWenjing Xie
Wenjing Xie
YNYubo Niu
Yubo Niu
HWHaonan Wang
Haonan Wang
WXWensheng Xie
Wensheng Xie
Necroptosis is a type of regulated cell death (RCD) that is triggered by changes in the extracellular or intracellular milieu that are picked up by certain death receptors. Thanks to its potent capacity to induce immunological responses and overcome apoptotic resistance, it has garnered significant attention as a potential cancer treatment. Basic information for the creation of nano-biomedical treatments is provided by studies on the mechanisms underlying tumor necroptosis. Receptor-interacting protein kinase 1 (RIPK1)–RIPK3-mediated necroptosis, Toll-like receptor domain-containing adapter-inducing interferon (IFN)-β (TRIF)–RIPK3-mediated necroptosis, Z-DNA-binding protein 1 (ZBP1)–RIPK3-mediated necroptosis, and IFNR-mediated necroptosis are the four signaling pathways that collectively account for triggered necroptosis in this review. Necroptosis has garnered significant interest as a possible cancer treatment strategy because, in contrast to apoptosis, it elicits immunological responses that are relevant to therapy. Thus, a thorough discussion is held on the connections between tumor cell necroptosis and the immune environment, cancer immunosurveillance, and cells such as dendritic cells (DCs), cytotoxic T cells, natural killer (NK) cells, natural killer T (NKT) cells, and their respective cytokines. Lastly, a summary of the most recent nanomedicines that cause necroptosis in order to cause immunogenic cell death is provided in order to emphasize their promise for cancer immunotherapy.

8 April 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
JLJingsong Lu
Jingsong Lu
ZGZhenhu Guo
Zhenhu Guo
WXWensheng Xie
Wensheng Xie
YCYongjie Chi
Yongjie Chi
JZJunxin Zhang
Junxin Zhang
Lingyun ZhaoLingyun Zhao
Lingyun Zhao
Schematic illustration of the preparation of Au-FeSe2 NCs and enhanced photo-radiotherapy for combined therapy.

24 October 2025 in ACS Nano
Verified
Journal Article
Closed access
GJGuangyao Jiang
Guangyao Jiang
FZFangming Zhang
Fangming Zhang
ZWZiyi Wu
Ziyi Wu
XZXianghong Zhang
Xianghong Zhang
JXJingxia Xu
Jingxia Xu
WXWensheng Xie
Wensheng Xie